# Handoff: Tracy → Clive

**Date**: 2025-12-30  
**From**: Tracy (Planning Specialist)  
**To**: Clive (Review Specialist)  
**Task**: Phase 8 Charts & Analytics Plan Review  
**Status**: 🔵 **AWAITING REVIEW**

---

## Context

Phase 8 implementation plan has been completed per Steve's handoff requirements. This phase builds on the successful Phase 7 (History) foundation and introduces interactive analytics capabilities.

---

## Deliverable

**Plan Document**: [Documentation/Plans/Phase_8_Charts_Analytics_Plan.md](../Plans/Phase_8_Charts_Analytics_Plan.md)

### Plan Highlights

**Scope**:
- Interactive blood pressure charts with clinical banding
- Statistical dashboard (min/avg/max, variability, morning/evening split)
- Time-range filtering (7d, 30d, 90d, 1y, all-time)
- Sleep data normalization (morning-after date, get-up time, deep/light/REM/awake stage minutes)
- Optional sleep quality correlation overlay + stacked sleep stages area chart
- Performance optimizations for large datasets

**Architecture**:
- **Service Layer**: New `AnalyticsService` for stats calculations, chart data prep, sleep correlation
- **ViewModel Layer**: `AnalyticsViewModel` managing state, caching, time range selection
- **View Layer**: `AnalyticsView` with reusable chart widgets (`BpLineChart`, `PulseLineChart`, stats cards)

**Key Technical Decisions**:
1. **Chart Library**: `fl_chart` (Flutter-native, customizable, good performance)
2. **Clinical Banding**: Horizontal zones (<130/85 green, 130-139/85-89 yellow, ≥140/90 red)
3. **Downsampling Strategy**: Smart sampling based on time range (raw for 7d, daily avg for 90d+)
4. **Sleep Schema Extension**: Stage minutes (deep/light/REM/awake) + get-up time derived from `endedAt`, migration with backfill
5. **Caching**: ViewModel-level caching with 5-minute TTL and invalidation on new data
6. **Morning/Evening Cutoff**: 12:00 PM (configurable)

**Coverage Targets**:
- Services: ≥85%
- ViewModels: ≥85%
- Widgets: ≥70%

---

## Review Requirements

Please review the plan for:

### 1. CODING_STANDARDS.md Compliance
- [ ] Architecture patterns align with established service → viewmodel → view flow
- [ ] Naming conventions follow standards (camelCase, PascalCase, snake_case files)
- [ ] Import organization specified correctly
- [ ] 80-character line limit considerations addressed
- [ ] Resource disposal strategy documented (chart controllers)
- [ ] Error handling approach defined

### 2. Technical Soundness
- [ ] Service layer responsibilities clearly defined and scoped
- [ ] ViewModel state management approach aligns with Provider patterns
- [ ] Chart data structures efficient and well-typed
- [ ] Statistical calculations mathematically correct (min/avg/max, std dev)
- [ ] Query optimization strategies realistic
- [ ] Caching strategy prevents stale data issues
- [ ] Downsampling logic preserves data integrity

### 3. Testing Strategy
- [ ] Unit test coverage comprehensive (service logic, calculations)
- [ ] Widget test scenarios cover critical user interactions
- [ ] Test cases include edge cases (empty data, single reading, outliers)
- [ ] Mock structure appropriate for isolated testing
- [ ] Coverage targets achievable and aligned with standards

### 4. Performance & Scalability
- [ ] Downsampling thresholds appropriate for mobile constraints
- [ ] Query limits prevent excessive data loading
- [ ] Chart rendering optimizations (RepaintBoundary, const constructors) documented
- [ ] Memory management strategy addresses potential leaks
- [ ] `compute()` isolate usage appropriate for heavy calculations

### 5. UX & Accessibility
- [ ] Clinical banding colors meet WCAG AA contrast requirements
- [ ] Text legend provided for colorblind accessibility
- [ ] Empty states clearly defined
- [ ] Loading indicators specified
- [ ] Error messaging user-friendly

### 6. Implementation Feasibility
- [ ] 10-day implementation timeline realistic
- [ ] Task sequencing logical (foundation → viewmodel → UI → polish)
- [ ] Dependencies identified and justified
- [ ] Rollback strategy viable if blockers encountered
- [ ] Risk assessment comprehensive with actionable mitigations

### 7. Alignment with Phase Requirements
- [ ] All tasks from [Implementation_Schedule.md](../Plans/Implementation_Schedule.md) addressed:
  - [x] Chart widgets with banding
  - [x] Time-range chips (7d/30d/90d/1y/all)
  - [x] Stats cards (min/avg/max, variability, morning/evening split)
  - [x] Sleep data normalization (date/get-up/stages) and stacked area chart
  - [x] Optional sleep correlation overlay
  - [x] Widget tests for rendering
  - [x] Performance checks
- [ ] Acceptance criteria measurable and aligned with schedule
- [ ] Dependencies on Phases 2, 4, 6, 7 acknowledged

---

## Specific Review Focus Areas

### Clinical Banding Accuracy
The plan specifies:
- **Normal**: <130 systolic AND <85 diastolic → Green
- **Elevated**: 130-139 systolic OR 85-89 diastolic → Yellow
- **High**: ≥140 systolic OR ≥90 diastolic → Red
- **Isolated Systolic**: ≥140 systolic AND <90 diastolic → Orange marker

**Question for Clive**: Do these thresholds match medical guidelines accurately? Should isolated diastolic hypertension be flagged similarly?

### Sleep Data Completeness
- Plan adds deep/light/REM/awake stage minutes, get-up time (endedAt), and morning-after alignment for correlation and stacked area chart.

**Questions for Clive**:
- Are stage fields sufficient (awake vs light split) for the planned visual?
- Any migration concerns for existing sleep entries—should we default stage minutes to null vs 0 and surface an "incomplete" badge?

### Statistical Calculation Validation
The plan includes standard deviation for variability. 

**Question for Clive**: Is coefficient of variation (CV) more appropriate for blood pressure variability, or is std dev sufficient?

### Downsampling Strategy
- 7d: All points (typically <50)
- 30d: All if <100, else daily averages
- 90d: Daily averages
- 1y+: Weekly averages

**Question for Clive**: Does this strike the right balance between data fidelity and performance?

### Sleep Correlation Complexity
Marked as optional due to potential scope creep.

**Question for Clive**: Should this be deferred to Phase 8.5, or is it core to Phase 8 acceptance?

---

## Files for Review

1. **Primary Plan**: [Documentation/Plans/Phase_8_Charts_Analytics_Plan.md](../Plans/Phase_8_Charts_Analytics_Plan.md)
2. **Implementation Schedule**: [Documentation/Plans/Implementation_Schedule.md](../Plans/Implementation_Schedule.md) (Phase 8 section)
3. **Coding Standards Reference**: [Documentation/Standards/Coding_Standards.md](../Standards/Coding_Standards.md)
4. **Phase 7 Pattern Reference**: [Documentation/Plans/Phase_7_History_Plan.md](../Plans/Phase_7_History_Plan.md) (architectural consistency)

---

## Handoff Instructions

### If Plan Approved
Create handoff document: `Documentation/Handoffs/Clive_to_Georgina.md` (or `Clive_to_Claudette.md` depending on implementer assignment)

Include:
- Approval confirmation with any conditions/caveats
- Specific areas requiring extra attention during implementation
- Testing priorities (e.g., "Focus on chart performance tests early")
- Any plan adjustments made during review

### If Plan Requires Revision
Create handoff document: `Documentation/Handoffs/Clive_to_Tracy.md`

Include:
- Specific sections requiring revision
- Blocking issues vs nice-to-have improvements
- Deadline for revised plan submission
- Clarifying questions answered

---

## Additional Context

**Grok Musings**: User provided [Documentation/Handoffs/Grok_to_Tracy.md](Grok_to_Tracy.md) with chart ideas (separate systolic/diastolic charts, stacked sleep area chart, PDF export). Treated as informational—plan focuses on core Phase 8 requirements first. Separate charts and PDF export can be revisited in Phase 9 (Export & Reports) or Phase 8.5 enhancements.

**Current Branch**: `feature/phase-8-charts-analytics` (Phase 7 cleanup committed)

**Test Suite Status**: 588 tests passing before Phase 8 work begins

---

## Success Criteria for This Handoff

- [ ] Clive confirms plan aligns with CODING_STANDARDS.md
- [ ] Technical approach validated (architecture, libraries, performance)
- [ ] Testing strategy deemed comprehensive
- [ ] Implementation timeline realistic
- [ ] Clinical accuracy verified (banding thresholds)
- [ ] Rollback strategy acceptable
- [ ] Plan greenlit for implementation OR specific revisions requested

---

**Tracy**  
Planning Specialist  
2025-12-30

**Next Action**: Clive to review plan and provide approval/revision feedback via handoff document.

